In the last trading session, 1.52 million Apogee Therapeutics Inc (NASDAQ:APGE) shares changed hands as the company’s beta touched 1.74. With the company’s per share price at $28.79 changed hands at -$3.51 or -10.87% during last session, the market valuation stood at $1.71B. APGE’s last price was a discount, traded about -120.56% off its 52-week high of $63.50. The share price had its 52-week low at $29.10, which suggests the last value was -1.08% down since then. When we look at Apogee Therapeutics Inc’s average trading volume, we note the 10-day average is 0.8 million shares, with the 3-month average coming to 668.71K.
Apogee Therapeutics Inc (NASDAQ:APGE) trade information
Instantly APGE was in red as seen at the end of in last trading. With action -19.15%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -36.45%, with the 5-day performance at -19.15% in the red. However, in the 30-day time frame, Apogee Therapeutics Inc (NASDAQ:APGE) is -23.31% down. Looking at the short shares, we see there were 8.16 million shares sold at short interest cover period of 10.72 days.
The consensus price target for the stock as assigned by Wall Street analysts is 95, meaning bulls need an upside of 69.69% from its current market value. According to analyst projections, APGE’s forecast low is 95 with 95 as the target high. To hit the forecast high, the stock’s price needs a -229.98% plunge from its current level, while the stock would need to soar -229.98% for it to hit the projected low.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
The 2025 estimates are for Apogee Therapeutics Inc earnings to decrease by -51.71%, but the outlook for the next 5-year period is at -22.96% per year.
APGE Dividends
Apogee Therapeutics Inc is expected to release its next quarterly earnings report on 2025-Mar-02.
Apogee Therapeutics Inc (NASDAQ:APGE)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 11.36% of Apogee Therapeutics Inc shares while 129.98% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 146.64%. There are 129.98% institutions holding the Apogee Therapeutics Inc stock share, with VR ADVISER, LLC the top institutional holder. As of 2024-06-30, the company held 15.0284% of the shares, roughly 8.49 million APGE shares worth $334.21 million.
FMR LLC holds the second largest percentage of outstanding shares, with 13.2812% or 7.51 million shares worth $295.36 million as of 2024-06-30.
Among Mutual Funds, the top two as of Jan 31, 2025 were VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund and Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund . With 2.0 shares estimated at $57.58 million under it, the former controlled 4.44% of total outstanding shares. On the other hand, Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund held about 3.12% of the shares, roughly 1.41 shares worth around $40.49 million.
